Cystic duct management in subtotal cholecystectomy: is closure necessary?

Kenichi Ishibayashi1, Kaichiro Kato1, Satoshi Takada1

  • 1Department of Hepato-Biliary-Pancreatic Surgery and Transplantation, Kanazawa University, 13-1 Takara-Machi, Kanazawa, Ishikawa, Japan.

Surgery Today
|July 9, 2026
PubMed

Insights

Subtotal cholecystectomy (SC) outcomes were compared with and without closure of the cystic duct orifice or remnant gallbladder. While complications were similar, non-closure was associated with longer hospital stays, suggesting careful patient selection is crucial.

Area of Science:

  • Gastroenterology and Hepatobiliary Surgery
  • Surgical Outcomes Research

Background:

  • The Tokyo Guidelines 2018 suggest subtotal cholecystectomy (SC) for severe cholecystitis.
  • Closure of the cystic duct orifice (CDO) or remnant gallbladder during SC is not always feasible.

Purpose of the Study:

  • To compare short-term outcomes of SC with and without closure of the CDO or remnant gallbladder.
  • To evaluate the impact of closure techniques on complication rates and length of stay.

Main Methods:

  • A retrospective study of 47 patients undergoing SC between 2012-2022.
  • Patients were divided into closure (n=35) and non-closure (n=12) groups.
  • Primary outcome: Clavien-Dindo (CD) grade ≥II complications; Secondary outcomes: intraoperative events, reinterventions, length of stay, mortality.

Main Results:

  • No significant difference in CD grade ≥II or ≥III complications between groups.
  • Higher rates of CD grade ≥III bile leakage in the non-closure group (25.0% vs 5.7%).
  • Significantly longer length of stay in the non-closure group (median 27.5 days vs 7 days; p<0.001).

Conclusions:

  • SC without closure may be suitable for carefully selected patients when closure is not feasible or safe.
  • Non-closure is associated with increased length of stay, highlighting the importance of closure when possible.
Abstract